Anthony Green

Anthony Green
Vice President, Technology Commercialization Group
Ben Franklin Technology Partners

Anthony P. Green, Ph.D., is Vice President, Technology Commercialization Group for Ben Franklin Technology Partners of Southeastern PA. He is also a Visiting Research Professor, School of Biomedical Engineering, Drexel University.  At Ben Franklin, Dr. Green is focused on Ben Franklin's earliest seed funding program, its mentoring and rapid prototyping program and helped create and manages the Drexel and Temple University co-investment programs—the first programs of their kind in the country.  Dr. Green leads Ben Franklin’s region-wide technology partnerships and major initiatives in emerging technologies focused on new and evolving life sciences initiatives, university/industry partnerships in medtech/digital health, advanced textiles, advanced manufacturing, nanotechnology, energy and the development and implementation new commercialization models.  He is a member of the Board of Visitors of the University of the Sciences Misher College of Arts and Sciences, PA Life Science Leadership Advisory Council and serves on the Oversight/Advisory Committees for the Coulter-Drexel Translational Research Partnership, the Science Center’s QED Program, Pediatric Medical Device Consortium and UPenn’s I-Corp program. He is also President of the Education Foundation of Lower Merion. Dr. Green has over 30 years experience in the biotechnology industry focusing on diagnostics and gene transfer technologies.  Dr. Green’s track record includes research, development and commercialization of cutting-edge technologies primarily through small, emerging companies, including Centocor, BD and Puresyn.  Dr. Green earned his Bachelor of Science degree in Immunology, with Honors, from Brown University, in Providence, Rhode Island and his Ph.D. from Temple University School of Medicine, in Microbiology and Immunology.

Recent Events and Presentations

January 11, 2017

Join ITIF and Brookings to discuss how the incoming administration and Congress can bolster technology transfer and commercialization policies to ensure that federal R&D investments yield stronger commercial results, in large part by better coordinating with regional economies.